Recent Advances in Controlled Release Technologies for the Co-delivery of Antimicrobial and Osteoconductive Therapeutics

Chukwuazam Nwasike,Kyle Reeser,Yizhong Liu,Jaspreet Singh Nagi,Erin Purr,Chendong Han,Amber L. Doiron

DOI: https://doi.org/10.1007/978-3-030-34471-9_2

2020-01-01

Abstract:Bone defects are a significant cause of morbidity in the fields of orthopedics, maxillofacial surgery, and oral implantology, yet their treatment currently faces many challenges including the defect size and location, underlying disease, and microbial infection. Bacteria may be introduced to healing bone through several routes including colonization during open-wound trauma, introduction during surgery, from blood-borne bacteria, or infection of a medical device such as a bone screw. Unfortunately, current treatment strategies are often inadequate and lead to severe and costly consequences. To tackle the problem of infection during bone healing, novel biomaterials such as scaffolds, cements, surface-modified implants, and particles have been developed that comprise both antimicrobial and osteoconductive properties. The antimicrobial properties of these biomaterials typically stem from the addition of antimicrobial agents like antibiotics and silver nanoparticles to the composite material, while osteoconductive properties are conveyed by biomolecules such as growth factors or hydroxyapatite. By controlling modes of delivery and/or release kinetics, these antibacterial and osteoconductive therapeutic constructs are potentially capable of significantly improving bone healing. Recent findings have shown very promising results in the application of these constructs with dual functions in treating infected bone defects. Here, we summarize the advances within the last decade in particle technologies, implant coatings, tissue engineering, and bone cements with both antimicrobial and osteoconductive activity with an emphasis on fabrication and the performance of constructs in various in vitro and in vivo models.